1. Patient treated for lymphoma, leukemia or inflammatory breast cancer ;

2. Patient with a solid tumour which location is other than breast or lung;

3. Patient with a tumor wound ;

4. Patient with a general condition \> 2 at baseline (ECOG classification) ;

5. Patient receiving anti-tumor treatment with radiotherapy exclusively or associated with concomitant radiotherapy ;

6. Patient unable to receive information about the study and to give consent ;

7. Persons deprived of liberty or guardianship ;

8. Impossible submission to study procedures for geographical or psychological reasons.

Study on Skin Toxicities Induced by Cancer Treatments